Medtronic Current Ratio 2010-2025 | MDT
Current and historical current ratio for Medtronic (MDT) from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Medtronic current ratio for the three months ending January 31, 2025 was 1.90.
| Medtronic Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-01-31 | $22.51B | $11.84B | 1.90 |
| 2024-10-31 | $22.44B | $12.20B | 1.84 |
| 2024-07-31 | $21.95B | $10.29B | 2.13 |
| 2024-04-30 | $21.94B | $10.79B | 2.03 |
| 2024-01-31 | $22.51B | $9.79B | 2.30 |
| 2023-10-31 | $22.08B | $9.66B | 2.29 |
| 2023-07-31 | $21.87B | $9.05B | 2.42 |
| 2023-04-30 | $21.68B | $9.05B | 2.40 |
| 2023-01-31 | $25.36B | $14.42B | 1.76 |
| 2022-10-31 | $25.40B | $14.47B | 1.76 |
| 2022-07-31 | $22.14B | $14.05B | 1.58 |
| 2022-04-30 | $23.06B | $12.39B | 1.86 |
| 2022-01-31 | $23.30B | $8.93B | 2.61 |
| 2021-10-31 | $22.73B | $7.80B | 2.91 |
| 2021-07-31 | $22.43B | $7.76B | 2.89 |
| 2021-04-30 | $22.55B | $8.51B | 2.65 |
| 2021-01-31 | $26.35B | $12.53B | 2.10 |
| 2020-10-31 | $26.04B | $12.07B | 2.16 |
| 2020-07-31 | $24.51B | $13.09B | 1.87 |
| 2020-04-30 | $22.03B | $10.37B | 2.13 |
| 2020-01-31 | $24.04B | $8.74B | 2.75 |
| 2019-10-31 | $22.65B | $8.17B | 2.77 |
| 2019-07-31 | $22.71B | $8.52B | 2.67 |
| 2019-04-30 | $21.97B | $8.47B | 2.59 |
| 2019-01-31 | $20.88B | $8.85B | 2.36 |
| 2018-10-31 | $21.65B | $8.46B | 2.56 |
| 2018-07-31 | $22.46B | $9.11B | 2.47 |
| 2018-04-30 | $22.98B | $10.08B | 2.28 |
| 2018-01-31 | $26.61B | $10.93B | 2.43 |
| 2017-10-31 | $25.16B | $10.50B | 2.40 |
| 2017-07-31 | $24.78B | $15.15B | 1.64 |
| 2017-04-30 | $24.87B | $14.26B | 1.74 |
| 2017-01-31 | $22.42B | $12.67B | 1.77 |
| 2016-10-31 | $22.53B | $9.60B | 2.35 |
| 2016-07-31 | $23.50B | $7.90B | 2.98 |
| 2016-04-30 | $23.60B | $7.17B | 3.29 |
| 2016-01-31 | $27.57B | $8.14B | 3.39 |
| 2015-10-31 | $28.72B | $8.13B | 3.54 |
| 2015-07-31 | $29.15B | $7.66B | 3.81 |
| 2015-04-30 | $30.84B | $9.17B | 3.36 |
| 2015-01-31 | $38.16B | $5.61B | 6.80 |
| 2014-10-31 | $21.60B | $6.95B | 3.11 |
| 2014-07-31 | $20.77B | $5.43B | 3.82 |
| 2014-04-30 | $21.21B | $5.56B | 3.82 |
| 2014-01-31 | $20.39B | $5.63B | 3.62 |
| 2013-10-31 | $19.48B | $5.50B | 3.55 |
| 2013-07-31 | $18.09B | $4.29B | 4.22 |
| 2013-04-30 | $17.85B | $3.95B | 4.52 |
| 2013-01-31 | $9.16B | $6.96B | 1.32 |
| 2012-10-31 | $9.44B | $6.62B | 1.43 |
| 2012-07-31 | $9.18B | $5.81B | 1.58 |
| 2012-04-30 | $16.34B | $5.93B | 2.76 |
| 2012-01-31 | $9.31B | $4.56B | 2.04 |
| 2011-10-31 | $9.01B | $4.73B | 1.90 |
| 2011-07-31 | $9.29B | $4.81B | 1.93 |
| 2011-04-30 | $9.15B | $4.73B | 1.94 |
| 2011-01-31 | $9.99B | $6.41B | 1.56 |
| 2010-10-31 | $9.89B | $5.90B | 1.68 |
| 2010-07-31 | $10.00B | $5.61B | 1.78 |
| 2010-04-30 | $9.84B | $5.12B | 1.92 |
| 2010-01-31 | $7.98B | $3.79B | 2.10 |
| 2009-10-31 | $7.31B | $3.28B | 2.23 |
| 2009-07-31 | $7.28B | $3.13B | 2.33 |
| 2009-04-30 | $7.45B | $3.15B | 2.37 |
| 2009-01-31 | $7.21B | $3.17B | 2.28 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $105.938B | $32.364B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $227.162B | 27.40 |
| Boston Scientific (BSX) | United States | $140.689B | 37.90 |
| Stryker (SYK) | United States | $132.255B | 28.42 |
| EssilorLuxottica (ESLOY) | France | $128.431B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.424B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.151B | 26.20 |
| ResMed (RMD) | United States | $31.269B | 24.08 |
| Agilent Technologies (A) | United States | $29.217B | 19.30 |
| GE HealthCare Technologies (GEHC) | United States | $28.556B | 13.89 |
| Terumo (TRUMY) | Japan | $28.160B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.192B | 15.85 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.373B | 12.24 |
| Insulet (PODD) | United States | $17.332B | 74.11 |
| Baxter (BAX) | United States | $14.818B | 10.66 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.356B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $7.609B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.938B | 17.06 |
| Bio-Rad Laboratories (BIO) | United States | $6.672B | 23.10 |
| Demant (WILYY) | Denmark | $6.644B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.977B | 18.98 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Perrigo (PRGO) | Ireland | $3.455B | 9.89 |
| ICU Medical (ICUI) | United States | $3.400B | 29.07 |
| Haemonetics (HAE) | United States | $2.872B | 13.52 |
| Envista Holdings (NVST) | United States | $2.614B | 20.80 |
| GN Store Nord (GNNDY) | Denmark | $2.188B | 14.75 |
| LeMaitre Vascular (LMAT) | United States | $1.946B | 44.47 |
| QuidelOrtho (QDEL) | United States | $1.698B | 14.22 |
| AtriCure (ATRC) | United States | $1.565B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.214B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.189B | 18.67 |
| AdaptHealth (AHCO) | United States | $1.051B | 10.12 |
| BioLife Solutions (BLFS) | United States | $1.041B | 0.00 |
| InMode (INMD) | Israel | $1.038B | 8.67 |
| Neogen (NEOG) | United States | $0.953B | 12.19 |
| Phibro Animal Health (PAHC) | United States | $0.700B | 10.74 |
| Evolus (EOLS) | United States | $0.686B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.649B | 0.00 |
| Valneva SE (VALN) | France | $0.552B | 0.00 |
| Owens & Minor (OMI) | United States | $0.535B | 4.56 |
| CeriBell (CBLL) | United States | $0.532B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.514B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.453B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.450B | 0.00 |
| Surmodics (SRDX) | United States | $0.394B | 0.00 |
| Omeros (OMER) | United States | $0.394B | 0.00 |
| SNDL (SNDL) | Canada | $0.368B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.328B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.302B | 13.07 |
| Viemed Healthcare (VMD) | United States | $0.262B | 23.68 |
| Sanara MedTech (SMTI) | United States | $0.262B | 0.00 |
| ZimVie (ZIMV) | United States | $0.261B | 15.65 |
| Sanuwave Health (SNWV) | United States | $0.256B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.251B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.250B | 44.40 |
| Cerus (CERS) | United States | $0.242B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Quanterix (QTRX) | United States | $0.200B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.189B | 0.00 |
| High Tide (HITI) | Canada | $0.187B | 0.00 |
| Biote (BTMD) | United States | $0.181B | 4.12 |
| TriSalus Life Sciences (TLSI) | United States | $0.175B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.172B | 13.24 |
| Brainsway (BWAY) | Israel | $0.155B | 48.47 |
| Jin Medical (ZJYL) | China | $0.147B | 0.00 |
| Organigram Global (OGI) | Canada | $0.135B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.123B | 15.42 |
| Agape ATP (ATPC) | $0.094B | 0.00 | |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.086B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.083B | 0.00 |
| Exagen (XGN) | United States | $0.080B | 0.00 |
| MacroGenics (MGNX) | United States | $0.079B | 0.00 |
| Veru (VERU) | United States | $0.078B | 0.00 |
| Fonar (FONR) | United States | $0.076B | 10.65 |
| Zynex (ZYXI) | United States | $0.066B | 24.22 |
| United Health Products (UEEC) | United States | $0.065B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.064B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| InterCure (INCR) | Israel | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.049B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 11.61 |
| Apyx Medical (APYX) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.036B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.035B | 51.50 |
| Safety Shot (SHOT) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.010B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |